Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
Aveta A, Cacciapuoti C, Barone B, Di Zazzo E, Del Giudice F, Maggi M, Ferro M, Terracciano D, Busetto GM, Lucarelli G, Tataru OS, Montanari E, Mirto BF, Falcone A, Giampaglia G, Sicignano E, Capone F, Villano G, Angellotto P, Manfredi C, Napolitano L, Imbimbo C, Pandolfo SD, Crocetto F. Aveta A, et al. Among authors: terracciano d. Cancers (Basel). 2022 Sep 29;14(19):4775. doi: 10.3390/cancers14194775. Cancers (Basel). 2022. PMID: 36230700 Free PMC article. Review.
Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with "gray" prostate-specific antigen levels at first biopsy: systematic review and meta-analysis.
Bruzzese D, Mazzarella C, Ferro M, Perdonà S, Chiodini P, Perruolo G, Terracciano D. Bruzzese D, et al. Among authors: terracciano d. Transl Res. 2014 Dec;164(6):444-51. doi: 10.1016/j.trsl.2014.06.006. Epub 2014 Jun 26. Transl Res. 2014. PMID: 25035153 Review.
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine.
Ferro M, Lucarelli G, Bruzzese D, Perdonà S, Mazzarella C, Perruolo G, Marino A, Cosimato V, Giorgio E, Tagliamonte V, Bottero D, De Cobelli O, Terracciano D. Ferro M, et al. Among authors: terracciano d. Anticancer Res. 2015 Feb;35(2):1017-23. Anticancer Res. 2015. PMID: 25667489 Free article.
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance.
de Cobelli O, Terracciano D, Tagliabue E, Raimondi S, Galasso G, Cioffi A, Cordima G, Musi G, Damiano R, Cantiello F, Detti S, Victor Matei D, Bottero D, Renne G, Ferro M. de Cobelli O, et al. Among authors: terracciano d. Urol Oncol. 2015 May;33(5):201.e1-8. doi: 10.1016/j.urolonc.2015.02.004. Epub 2015 Mar 16. Urol Oncol. 2015. PMID: 25791753
Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.
De Cobelli O, Buonerba C, Terracciano D, Bottero D, Lucarelli G, Bove P, Altieri V, Coman I, Perdonà S, Facchini G, Berretta M, Di Lorenzo G, Grieco P, Novellino E, Franco R, Caraglia M, Manini C, Mirone V, De Placido S, Sonpavde G, Ferro M. De Cobelli O, et al. Among authors: terracciano d. Future Oncol. 2015 Nov;11(22):3091-8. doi: 10.2217/fon.15.249. Epub 2015 Sep 18. Future Oncol. 2015. PMID: 26381851 Free PMC article.
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging.
de Cobelli O, Terracciano D, Tagliabue E, Raimondi S, Bottero D, Cioffi A, Jereczek-Fossa B, Petralia G, Cordima G, Almeida GL, Lucarelli G, Buonerba C, Matei DV, Renne G, Di Lorenzo G, Ferro M. de Cobelli O, et al. Among authors: terracciano d. PLoS One. 2015 Oct 7;10(10):e0139696. doi: 10.1371/journal.pone.0139696. eCollection 2015. PLoS One. 2015. PMID: 26444548 Free PMC article.
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
Ferro M, De Cobelli O, Buonerba C, Di Lorenzo G, Capece M, Bruzzese D, Autorino R, Bottero D, Cioffi A, Matei DV, Caraglia M, Borghesi M, De Berardinis E, Busetto GM, Giovannone R, Lucarelli G, Ditonno P, Perdonà S, Bove P, Castaldo L, Hurle R, Musi G, Brescia A, Olivieri M, Cimmino A, Altieri V, Damiano R, Cantiello F, Serretta V, De Placido S, Mirone V, Sonpavde G, Terracciano D. Ferro M, et al. Among authors: terracciano d. Medicine (Baltimore). 2015 Oct;94(42):e1861. doi: 10.1097/MD.0000000000001861. Medicine (Baltimore). 2015. PMID: 26496339 Free PMC article.
Biomarkers in localized prostate cancer.
Ferro M, Buonerba C, Terracciano D, Lucarelli G, Cosimato V, Bottero D, Deliu VM, Ditonno P, Perdonà S, Autorino R, Coman I, De Placido S, Di Lorenzo G, De Cobelli O. Ferro M, et al. Among authors: terracciano d. Future Oncol. 2016 Feb;12(3):399-411. doi: 10.2217/fon.15.318. Epub 2016 Jan 15. Future Oncol. 2016. PMID: 26768791 Free PMC article. Review.
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review.
Di Lorenzo G, De Placido S, Pagliuca M, Ferro M, Lucarelli G, Rossetti S, Bosso D, Puglia L, Pignataro P, Ascione I, De Cobelli O, Caraglia M, Aieta M, Terracciano D, Facchini G, Buonerba C, Sonpavde G. Di Lorenzo G, et al. Among authors: terracciano d. Expert Opin Biol Ther. 2016 Nov;16(11):1387-1401. doi: 10.1080/14712598.2016.1216964. Epub 2016 Aug 5. Expert Opin Biol Ther. 2016. PMID: 27463642
145 results